# A Novel Compound for Alcoholism Treatment

> **NCT02039349** · PHASE1 · COMPLETED · sponsor: **National Institute on Alcohol Abuse and Alcoholism (NIAAA)** · enrollment: 14 (actual)

## Conditions studied

- Alcoholism
- Alcohol-Related Disorders
- Alcohol Dependence
- Alcohol Drinking Related Problems
- Alcohol Drinking

## Interventions

- **DRUG:** PF-05190457

## Key facts

- **NCT ID:** NCT02039349
- **Lead sponsor:** National Institute on Alcohol Abuse and Alcoholism (NIAAA)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2014-01-03
- **Primary completion:** 2015-10-01
- **Final completion:** 2017-12-24
- **Target enrollment:** 14 (ACTUAL)
- **Last updated:** 2019-12-16

## Collaborators

- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02039349

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02039349, "A Novel Compound for Alcoholism Treatment". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT02039349. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*